Embodiments are directed to a series of novel EPAC antagonists that are designed, synthesized and evaluated in an effort to develop diversified analogues based on the scaffold of the previously identified high-throughput (HTS) hit ESI-09.
本发明实施例涉及一系列新型 E
PAC 拮抗剂,这些拮抗剂的设计、合成和评估是为了在先前确定的高通量(H
TS)研究热点 ESI-09 的支架基础上开发多样化的类似物。